Rui Sun

Statistics

Publications

Citations

705

H-Index

Active since

1997

Affiliations

The University of Texas Southwestern Medical Center(Current)

Novartis (United States)

Novartis (Switzerland)

Rui Sun is an author at The University of Texas Southwestern Medical Center specializing in medicine, anesthesia, and onasemnogene abeparvovec therapy.

ORCID

Publications per year

1997–2024

Publications

Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy

Deepa H. Chand, F. Mohr, Hugh J. McMillan et al. · Journal of Hepatology · 2020 · 297 citations · Full text

Medicine, Pharmacology, Toxicology +17

The Effect of Timing of Ondansetron Administration in Outpatients Undergoing Otolaryngologic Surgery

Rui Sun, Kevin W. Klein, Paul F. White · Anesthesia & Analgesia · 1997 · 128 citations

Medicine, Otolaryngology, Surgery +13

The Effect of Timing of Ondansetron Administration in Outpatients Undergoing Otolaryngologic Surgery

Rui Sun, Kevin W. Klein, Paul F. White · Anesthesia & Analgesia · 1997 · 114 citations

Medicine, Otolaryngology, Surgery +13

Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry

Laurent Servais, Darryl C. De Vivo, Janbernd Kirschner et al. · Journal of Neuromuscular Diseases · 2024 · 65 citations · Full text

Medicine, Molecular Medicine, Pharmacotherapy +14

A Cost Comparison of Methohexital and Propofol for Ambulatory Anesthesia

Rui Sun, Mehernoor F. Watcha, Paul F. White et al. · Anesthesia & Analgesia · 1999 · 38 citations

Medicine, Anesthesiology, Pharmacoeconomics +17

1–5 of 8